Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,819
Closed -$280K 55
2024
Q4
$280K Sell
2,819
-1
-0% -$103 0.17% 52
2024
Q3
$320K Sell
2,820
-6
-0.2% -$713 0.2% 51
2024
Q2
$350K Sell
2,826
-40
-1% -$5.15K 0.23% 47
2024
Q1
$378K Sell
2,866
-6
-0.2% -$740 0.25% 46
2023
Q4
$313K Sell
2,872
-39
-1% -$4.05K 0.22% 46
2023
Q3
$300K Buy
2,911
+55
+2% +$5.93K 0.24% 46
2023
Q2
$330K Hold
2,856
0.25% 44
2023
Q1
$304K Hold
2,856
0.24% 47
2022
Q4
$317K Sell
2,856
-13
-0.5% -$1.33K 0.27% 45
2022
Q3
$247K Buy
2,869
+295
+11% +$26.3K 0.23% 46
2022
Q2
$235K Buy
2,574
+57
+2% +$5.05K 0.21% 45
2022
Q1
$207K Sell
2,517
-665
-21% -$52.4K 0.16% 48
2021
Q4
$244K Buy
+3,182
New +$253K 0.17% 41

Other funds holding MRK

William Allan Corp's MRK Position: Q1 2025 in Review

William Allan Corp sold out of Merck (MRK) in Q1 2025, closing a stake of 2,819 shares — an estimated $280K sold.

William Allan Corp first reported a position in MRK in Q4 2021 and held it in 13 quarters. The position peaked at $378K in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • William Allan Corp reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • William Allan Corp sold 2,819 Merck shares in Q1 2025, an estimated $280K.
  • William Allan Corp first reported a position in Merck in Q4 2021 and held it in 13 quarters.
  • William Allan Corp's Merck position peaked at $378K in Q1 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on William Allan Corp's 13F filing for Q1 2025, filed 5 May 2025.